ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 1b, Single Center, Clinical Study to Investigate the Safety and Biological Responses to Baminercept in Patients With Chronic HCV Hepatitis.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01164384
Recruitment Status : Unknown
Verified July 2010 by University of Zurich.
Recruitment status was:  Not yet recruiting
First Posted : July 16, 2010
Last Update Posted : July 16, 2010
Sponsor:
Collaborator:
PD Dr. rer. nat. Mathias Heikenwälder
Information provided by:
University of Zurich

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Study Completion Date : February 2013